Objectives

We are maintaining our focus towards launching Prevagen™ as a natural supplement as we continue to develop future pharmaceutical applications through Quincy Bioscience. Two new labs will be announced in 2007 at the University of Wisconsin in Madison that are now partnered with Quincy Bioscience researching the role of aequorin in stroke disease as well as chronic inflammation like that which is found in arthritis and autoimmune diseases. We have established a well grounded board of directors as well as a developing Scientific Advisory Panel to help us continue to move forward as we plan and grow towards the future.